TRIB3 is a known regulator of MAPK–ERK pathway in cancer and cardiomyopathy models (Tang et al., 2008; Izrailit et al., 2013) by directly interacted with ERK or increased posttranslational phosphorylation. The gene discussed is TRIB3; the disease is cardiomyopathy.